Responsiveness of Choroidal Neovascular Membranes in Patients With R345W Mutation in Fibulin 3 (Doyne Honeycomb Retinal Dystrophy) to Anti–Vascular Endothelial Growth Factor Therapy
- 1 December 2011
- journal article
- case report
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 129 (12), 1626
- https://doi.org/10.1001/archophthalmol.2011.338
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in miceHuman Molecular Genetics, 2007
- Maculopathy Due to the R345W Substitution in Fibulin-3: Distinct Clinical Features, Disease Variability, and Extent of Retinal DysfunctionPublished by Association for Research in Vision and Ophthalmology (ARVO) ,2006
- Malattia leventinese presenting with subretinal neovascular membrane and hemorrhageAmerican Journal of Ophthalmology, 2001
- A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophyNature Genetics, 1999